24 Greville Street
EC1N 8SS
+44 (0) 203 0084416
+44 (0) 203 0084415
K Alexander
ValiRx Plc is a biopharmaceutical company developing novel technologies and products in oncology therapeutics and diagnostics. The product focus is in the epigenomic analysis and treatment of cancer, but the technologies can be applied to other fields as well, such as neurology and inflammatory diseases.
| Description | Report Date | Published |
|---|---|---|
| Annual Report 2010 | 31-12-2010 | 26-05-2011 |
| Annual Report 2009 | 31-12-2009 | 03-06-2010 |
| Annual Report 2008 | 31-12-2008 | 01-01-1970 |
| Annual Report 2007 | 31-12-2007 | 01-01-1970 |
| Description | Report Date | Published |
|---|---|---|
| Interim Report 2011 | 30-06-2011 | 22-09-2011 |
| Interim Report 2010 | 30-06-2010 | 30-09-2010 |
| Interim Report 2009 | 30-06-2009 | 25-09-2009 |
| Interim Report 2008 | 30-06-2008 | 01-01-1970 |
| Interim Report 2007 | 30-06-2007 | 28-09-2007 |
| Description |
|---|
| Home |
| Results Index |
| Press Releases |
| Contacts |
| Type | Dividend | Payment Date |
|---|